Status:
COMPLETED
Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China
Lead Sponsor:
Peking University First Hospital
Collaborating Sponsors:
China Cardiovascular Association
AstraZeneca
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective, researcher-initiated, database-based study that will retrospectively observe the treatment and medication patterns of about 22,500 patients with heart failure from 25 heart fa...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- An index HF diagnosis date in the records
- Age ≥ 18 years old at initial diagnosis date
- HF patients baseline characteristic record
Exclusion
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
22500 Patients enrolled
Trial Details
Trial ID
NCT06099028
Start Date
September 1 2021
End Date
March 31 2023
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Peking University First Hospital
Beijing, China, 100034